CD388

· Cidara Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for CD388, covering 2024-09-05 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Effect of CD388 on the Immunogenicity of Fluzone® HD Vaccine [Phase 1]